Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Sovcombank reported for 9 months of 2023 according to IFRS

11/30/23 SVCB

Yandex will start leasing Rovers to other companies

11/30/23 YNDX

Sovcombank acquired insurance company InLife

11/30/23 SVCB

Prices for Rostelecom's services to competitors may increase by 10%

11/30/23 RTKM

SPB Exchange will launch a number of new projects in early 2024

11/30/23 SPBE

INARCTICA completes SPO with oversubscription

11/30/23 AQUA

Rosneft reported for 9 months of 2023 by IFRS

11/30/23 ROSN

Salesforce reported for 9 months of fiscal year 2024

11/30/23 CRM

Rosneft increased gas production by 33%

11/30/23 ROSN

Bashneft reported for 9 months of 2023 by IFRS

11/30/23 BANE